Tempest Therapeutics, Inc. Common Stock
TPST Real Time Price USDRecent trades of TPST by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TPST's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Bicyclic carboxamides and methods of use thereof Oct. 24, 2023
-
Patent Title: Bicyclic compounds and their use in the treatment of cancer Aug. 29, 2023
-
Patent Title: Triazolone compounds and uses thereof Jun. 06, 2023
-
Patent Title: Bicyclic compounds and their use in the treatment of cancer May. 02, 2023
-
Patent Title: Bicyclic carboxamides and methods of use thereof Oct. 18, 2022
-
Patent Title: Bicyclic carboxamides and methods of use thereof Sep. 13, 2022
-
Patent Title: Bicyclic compounds and their use in the treatment of cancer Jul. 20, 2021
-
Patent Title: Bicyclic carboxamides and methods of use thereof Apr. 06, 2021
-
Patent Title: Triazolone compounds and uses thereof Feb. 25, 2020
-
Patent Title: Pyrazolone compounds and uses thereof Jan. 09, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of TPST in WallStreetBets Daily Discussion
Recent insights relating to TPST
Recent picks made for TPST stock on CNBC
ETFs with the largest estimated holdings in TPST
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TPST Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.